Geode Capital Management LLC increased its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 1.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 6,381,525 shares of the real estate investment trust's stock after buying an additional 86,727 shares during the period. Geode Capital Management LLC owned 2.70% of Sabra Health Care REIT worth $110,550,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. grew its stake in shares of Sabra Health Care REIT by 222.4% in the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust's stock valued at $183,996,000 after acquiring an additional 6,819,919 shares in the last quarter. Vestcor Inc boosted its stake in Sabra Health Care REIT by 62.5% in the third quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust's stock valued at $3,869,000 after buying an additional 79,956 shares in the last quarter. Barclays PLC grew its holdings in shares of Sabra Health Care REIT by 56.1% during the 3rd quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust's stock valued at $12,624,000 after purchasing an additional 243,895 shares during the last quarter. Franklin Resources Inc. increased its holdings in shares of Sabra Health Care REIT by 12.3% during the third quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust's stock worth $9,543,000 after buying an additional 57,551 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in Sabra Health Care REIT by 13.0% in the 4th quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock worth $69,967,000 after purchasing an additional 463,601 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.
Sabra Health Care REIT Stock Up 1.2 %
NASDAQ:SBRA traded up $0.21 on Tuesday, hitting $17.87. The stock had a trading volume of 170,943 shares, compared to its average volume of 2,122,255. The firm's fifty day simple moving average is $16.90 and its two-hundred day simple moving average is $17.54. The stock has a market cap of $4.25 billion, a P/E ratio of 33.70, a price-to-earnings-growth ratio of 1.97 and a beta of 0.93. Sabra Health Care REIT, Inc. has a 1 year low of $13.31 and a 1 year high of $20.03. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting analysts' consensus estimates of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The firm had revenue of $182.35 million for the quarter, compared to analysts' expectations of $178.01 million. Analysts predict that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.
Sabra Health Care REIT Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.72%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT's dividend payout ratio (DPR) is presently 226.42%.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on SBRA. Truist Financial raised their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Tuesday, March 18th. Citizens Jmp upgraded Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 7th. Finally, JMP Securities upgraded Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 target price for the company in a research note on Tuesday, January 7th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $19.33.
View Our Latest Report on Sabra Health Care REIT
Sabra Health Care REIT Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Stories
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
